Disclaimer

Please read this page before proceeding further. By clicking to log into this site, you are agreeing that you have reviewed and agreed on the terms and conditions contained herein.

This website is not intended for the general public. It is designed for use by Professional clients and other eligible counterparties as defined under Maltese Regulations. You must agree to the terms and conditions set forth below for your own behalf and for all others, on whose behalf you access the Company website and acquire information about Fund Scouting & Advisory Limited (“the Company”). The Company is licensed by the Malta Financial Services Authority to provide investment services as a Category 1b in terms of the Investment Services Act (1994) and is also authorized to provide its services in Italy and Luxembourg.

Access subject to local restrictions

This website and the information which is contained in it or otherwise incorporated by reference has not been and will not be submitted to, become approved by or verified by or registered with any relevant regulatory authorities under local laws. This website is not intended for and should NOT be accessed by persons who are located or resident in any jurisdiction where (by reason of that person’s nationality, domicile, residence or otherwise) the publication or availability of this website is prohibited or contrary to local law or regulation or which would subject the Company to any registration or licensing requirements in such jurisdiction.

The information found on this website should not be circulated or distributed to any person other than to any professional investors or eligible counterparties (as defined in local laws and regulations), and should not be relied upon by any other persons or redistributed to the retail public in relevant countries.

No Offer or Solicitation

The information contained and referenced on this website (including without limitation the information, functions and documents herein (hereinafter referred to as the “Contents”) is supplied solely for information purposes only and should not be regarded as an offer, solicitation or recommendation for any investments, investment funds or products in any jurisdiction where such activity is unlawful. The Contents have been prepared without taking into consideration the investment objectives, financial situation or means of any person or entity and the website is not soliciting any action based upon them. The Contents are not to be construed as a recommendation or an offer or invitation to trade in any units of funds nor should any Contents form the basis of, or be relied upon in connection with, any contract or commitment on the part of any person to proceed with any transaction. The Contents are not to be construed as soliciting or promoting any financial products or services. This website is not directed at you, if we are prohibited by any law or regulation of any jurisdiction from making the information on this site available to you and is not intended for any use which would be contrary to local law or regulation. In particular, the Contents of this website are not aimed at the dissemination in the United States of America or to U.S. citizens, in ways other than in accordance with U.S. Laws. If you are visiting our web site from any such jurisdiction, please kindly disconnect from our web pages.

No Warranty

The Contents are published in good faith. No advice, representation or warranty, express or implied is made by the Company or by any person as to its adequacy, accuracy, completeness, reasonableness or that it is fit for your purpose and it should not be relied on as such. Every effort has been made to ensure the accuracy of the Contents, but it may be based on outdated data or subject to errors. Furthermore, you must acknowledge that past performance is not indicative of future performance. The price of investment instruments can go down as well as up and may be affected by changes in rates of exchange. An investor may not get back the amount invested. Any investments may involve significant risks. Whilst it is the intention of the Company to provide the right investment advice, there can be no assurance that these investments will be successful. It is possible that an investor may lose a substantial proportion or all of its investment. As a result, each investor should carefully consider whether it can afford to bear the risks of conducting its investment. Investors should read the offering documents for further details including the risk factors before making an investment.

No Tax or Legal Advice

Potential investors should inform themselves as to (a) the possible tax consequences, (b) the legal requirements and (c) any foreign exchange restrictions or exchange control requirements which they might encounter under the laws of the countries of their citizenship, residence, incorporation or domicile and which might be relevant to the subscription, holding, or disposal of any units of investments. It is the responsibility of any persons in possession of any marketing material or any documentation with respect to any instrument or security and any persons wishing to apply for services, for their own purposes or on behalf of others, to inform themselves of, and to observe and comply with, all applicable laws and regulations of any relevant jurisdiction. Prospective investors should inform themselves as to the legal requirements of so applying and any applicable exchange control requirements and taxes in the countries of their nationality, residence or domicile. Statements made in any documents, except where otherwise stated, are based on the law and practice currently in force of the respective jurisdiction and are subject to changes therein.

If you are unsure about the meaning of any information provided, please consult your financial or other professional adviser.

No Liability

The Company shall have no liability for any loss or damage arising in connection with this website or out of the use, in ability to use or reliance on the Contents by any person, including without limitation, any loss of profit or any other damage, direct or consequential, regardless of whether they arise from contractual or tort (including negligence) or whether the Company has foreseen such possibility, except where such exclusion or limitation contravenes the applicable law. By accessing certain links on this website, you may leave this website. The Company has not examined any of the linked websites and does not assume any responsibility for the contents of such websites, nor the services, products or items offered through such websites.

In order to proceed and access more information you must confirm that you have read, fully understood and accept the terms as defined above by clicking the “AGREE” button below.
I agree

News


DateTitleAbstractLink
12.09.2022
Active Solar did well in August compared to the negative stock markets
The positive YTD performance stands out in the heavy correction endured by most stock indexes.
Read more
01.09.2022
Medtech & Services sector lives up to its reputation - comment by Marcel Fritsch
Sector rotation into value has lost considerable momentum and investors are showing more interest in fast-growing, innovative, non-cyclical stocks. This has put medtech & services companies (back) on the radar of the general investment community.
Read more
08.08.2022
Bellevue Managers confident future of global healthcare industry is bright one
Here is the latest article in the Mail on Sunday mentioning Bellevue Healthcare Trust from "This is Money UK"
Read more
27.07.2022
Bellevue Healthcare Strategy – GARP poised for a comeback
The fund's PEG ratio (price/earnings ratio relative to earnings growth) has never been as low as it is now. That is a sign of fair valuations and enticing investment opportunities. Samuel Stursberg explains why the time is ripe for a comeback by profitable growth companies and how the portfolio will benefit from it.
Read more
27.07.2022
SFM INTERVIEW: REDHEDGE ON REPO LIQUIDITY CHALLENGES
In this article Andrea Seminara, portfolio manager of the RedHedge Relative Value Fund, discusses the recent liquidity conditions in the Repo sector and how the fund is performing in this market environment.
Read more
06.07.2022
RedHedge once again in the TOP 10 performer funds for May 2022 according to BarclayHedge
Once again RedHedge Relative Value UCITS Fund Class A USD has ranked number 7 in the Fixed Income - Arbitrage category for May 2022 according to BarclayHedge’s Monthly performance rankings.
Read more
05.07.2022
2022's historic opportunities for healthcare investors
Paul Major, portfolio manager for Bellevue Healthcare Trust (BBH.L) joined Richard Kimberley at Kepler Trust Intelligence to discuss how the strategy is looking to take advantage of recent volatility, in what he says is likely to be remembered as a historic buy opportunity for investors.
Read more
22.06.2022
Emerging Markets Healthcare – Remo Krauer Update
Recent quarterly figures and outlooks of many Asian healthcare companies remain robust and encouraging, despite ongoing political and macroeconomic uncertainties. Remo Krauer, PM of the Bellevue Emerging Market Healthcare fund, explains background and impact of the current developments. https://www.bellevue.ch/ch-en/pro/insights/bellevue-insights-emerging-markets-healthcare#history-back
Read more
15.06.2022
Stock pension – Loys PM view on Germany
Ufuk Boydak and Dr. Christoph Bruns, fund managers of Loys Aktien Europa and Loys Global L/S funds, in this recent article analyse the German government choices regarding the share-based pension scheme.
Read more
14.06.2022
Are we living in a post-Covid world? Listen to the podcast with Paul Major, PM of the Bellevue Healthcare Trust.
Paul Major of Bellevue Healthcare Trust and Covid-19 researcher and oncologist Prof. Justin Stebbing, discuss the ongoing transition to a post-Covid-19 world.
Read more
09.06.2022
Redhedge Relative Value UCITS class A USD Fund in the TOP 10 BarclayHedge’s Monthly Performance rankings
The fund has ranked number 7 in the Fixed Income – Arbitrage category for April 2022. An important recognition of the excellence of those products that stands out for performance, volatility and consistency over time.
Read more
08.06.2022
Can we benefit from the diverse characteristics of the healthcare sector?
In this interview, Dr. Terence McManus outlines the investment strategy of the new Bellevue Diversified Healthcare Fund.
Read more
07.06.2022
May 2022 News – Active Solar Fund performed well
Performance has been very positive in May. Is there a prospect for an upward movement similar to the one we saw in 2020? Here’s the commentary from PM Pascal Rochat.
Read more
31.05.2022
Has the pandemic reshaped the Healthcare sector?
Paul Major of the Bellevue Healthcare Trust tells to The Daily Telegraph how the pandemic made doctors more willing to try new approaches to care.
Read more
18.05.2022
The Belt tightening of the German government
Ufuk Boydak, PM of the LOYS Aktien Europa and LOYS Global L/S Funds, and Dr. Christoph Burns on the current market environment and the role German Government is playing in managing the actual geopolitical situation.
Read more
17.05.2022
Biotech sector sees potential for growth post Covid
In this article from Wealthadviser, Dallas Webb, Portfolio Manager of the Bellevue BB Biotech fund analyses opportunities in the Biotechnology sector.
Read more
11.05.2022
RedHedge Asset Management April 2022 News – Active Solar Fund corrected but this remains an interesting entry pointhis team – Meet William Moorhouse, Product Specialist
April 2022 has been a difficult month for the fund, mainly in relation to the uncertainties on the US Solar market, but which doesn’t affect the attractiveness of this thematic Fund.
Read more
06.05.2022
RedHedge Asset Management introduces his team – Meet William Moorhouse, Product Specialist
In this short video William Moorhouse, Product Specialist of the London Asset Management company, tell us all about his role and his favourite things about working at RedHedge Asset Management LLP.
Read more
03.05.2022
Active Solar won Best Fund over 3 and 5 years at Nordics Refinitiv Lipper Fund Awards 2022
A great award for the Active Solar Fund which wins the “Best Fund over 3 years” and “Best Fund over 5 years” for the Equity Theme – Alternative Energy category at the Nordics Refinitiv Lipper Fund Awards 2022. Two great victories which are representative of the commitment and the competence of the Fund Manager Pascal Rochat, capable of generating excellent performance over time.
Read more
28.04.2022
Gamma Capital – Eiger Robotics Fund obtains two major awards from Citywire Italy
3rd place in terms of total return in the first three months of 2022 and 1st place in terms of standard deviation (9.3) over a 3-year period (2019-2022) for the Global Equity Tech Thematic class. A great result for Carlo De Luca, PM of the Fund, capable of achieving great performance, generating excellent long-term results.
Read more
27.04.2022
Is normalization of surgery volumes positive for medtech companies? Here the answer from Marcel Frisch
Normalization of surgery volumes is positive for medtech companies and US health insurers are benefitting in an environment of rising interest rates. Marcel Fritsch, Portfolio Manager of the Bellevue Medtech & services fund, discusses the current year and the investment strategy.
Watch here
26.04.2022
Digital Health: encouraging company specific news flow – Stefan Blum talks about the Bellevue Digital Health fund
Encouraging company specific news flow, lower valuation multiples and challenges around healthcare workforce are positive factors for the digital health investment case. Stefan Blum, Portfolio Manager of the Bellevue Digital Health fund, discusses the current year and the investment strategy.
Watch here
21.04.2022
Bellevue’s Paul Major: investing to solve healthcare problems
In this article Paul Major tells Mary McDougall why there is a “tremendous buying opportunity” in small and mid caps.
Read more
19.04.2022
Another award for MOMentum Multilabel Sicav – Lyra
Multilabel Sicav - LYRA Fund makes 3 out of 3 in 2022, collecting the fifth Lipper Award since 2018 as "Best Fund over 3 Years - Mixed Asset EUR Flex - Europe". Congratulations to the fund manager, Gianluca Pediconi, for another recognition, which confirms not only the great professionalism, but also the extreme competence in management capable of generating superior performance over time.
Read more
13.04.2022
How Trium and other four fund managers are playing the healthcare sector
Raphael Pitoun, Portfolio Manager of Trium Sustainable Innovators Fund, discusses the escalating costs in Healthcare and how MCOs (managed care organisations) are helping to address the problem.
Read more
13.04.2022
Underestimated newcomers – Bellevue commentary on the mid-cap Biotech companies
The steadily growing importance of small and mid-cap biotech companies with innovative product pipelines has not yet been fully acknowledged by financial markets. Here’s the market commentary by Dr. Daniel Koller.
Read more
07.04.2022
War in Ukraine – Monthly commentary from the Fund managers
The unimaginable for many has become reality: war reigns again in Europe. Once again, Carl Von Clausewitz was right: "War is the continuation of politics by other means." Here attached the monthly commentary from Dr. Christoph Bruns and Ufuk Boydak, fund managers and co-investors LOYS Aktien Europa and LOYS Global L / S.
Read more
06.04.2022
China’s Healthcare industry at a turning point
Remo Krauer, Senior Portfolio Manager of the Bellevue Healthcare Asia Pacific fund, shares his point of view concerning the Healthcare industry in China, which recently made further significant progress in terms of quality and its international profile.
Read more
06.04.2022
Active Solar - News of the Month - March 2022
Active Solar returned a good performance in March, mainly driven by the energy crisis triggered by the Russia-Ukraine war. Read the full news.
Read more
05.04.2022
Digitization of the healthcare sector
Stefan Blum, portfolio manager of the Bellevue Digital Health Fund, provides in-depth insights into the topic of digitization in healthcare.
Read more
30.03.2022
MOMentum Multilabel SICAV – LYRA gains Citywire AAA rating
The fund manager outperformed his benchmark over a three-year period and obtained the highest AAA rating. Only the 10% of managers screened by Citywire (over 16,000 fund managers in 64 countries) has been able to achieve this, entering in an outstanding elite group.
Read more
22.03.2022
MOMentum Multilabel SICAV – LYRA wins at the 2022 UCITS Hedge Awards
It is a matter of sustainable, consistent and superior returns. The MOMentum Multilabel SICAV – LYRA won the "Long / Short Equity Europe, Best Performing Fund over 7 years" category, published by The Hedge Fund Journal.
Read more
17.03.2022
BEST AND WORST FUNDS SINCE THE UKRAINE INVASION STARTED
Active Solar has been the second best performing fund since the start of the Ukraine invasion - Article from Citywire 7th March 22.
Read more
01.03.2022
FSA strengthens its commercial Team in Italy and Switzerland and hires a new Institutional Sales
The appointment of a new Institutional Sales will enable the firm's institutional sales team to deepen its focus on the Italian and Switzerland markets.
Read more
01.10.2021
Loys aktien europa presentation
Read the latest presentation of the Loys Aktien Europa fund.
Read more
01.10.2021
Loys Global presentation
Read the latest presentation of the Loys Global fund.
Read more
22.09.2021
MARKET FLASH - 22 SEPTEMBER 2021
Gemway Assets' latest market flash, approaching investors' concerns about Evergrande default risk and a potential risk of contagion on the Chinese financial system in general.
Read more
04.09.2021
Redhedge CIO Andrea Seminara interviewed on Plus24
Andrea Seminara gives his outlook on the current bond market on the latest issue of Plus24.
Read more
11.06.2021
Trium Capital

In June 2021, Raphael Pitoun brought his global and US ESG strategies over from CQS to Trium Capital. The linked document gives an overview of his funds' strategy and performance.

Read more
10.06.2021
BARCLAYHEDHGE EXCELLENCE AWARD FOR REDHEDGE
BarclayHedge awards Redhedge's Relative Value UCITS fund the Recognition Award for Excellence as a top performer in April 2021 in the Fixed Income - Arbitrage category.
Read more
01.06.2021
LIVESTREAM DIGITAL HEALTH - REVOLUTION IN HEALTHCARE
Marcel Fritsch and Stefan Blum, the Co-Lead portfolio managers of the BB Adamant Digital Health (Lux) fund, present a livestream on the topic of "Digital Health - Revolution in Healthcare".
Watch
18.02.2021
BB Insights Video Update - Medtech & Services - February 2021

Marcel Fritsch and Stefan Blum, portfolio managers of the BB Adamant Medtech & Services and BB Adamant Digital Health review the market situation, new opportunities and some of the companies best positioned to navigate the current uncertainty caused by the pandemic.

Watch
08.02.2021
M&A OPPORTUNITIES INVESTOR LETTER – Q4 2020

Massimo Stabilini, advisor for Aristea SICAV M&A Opportunities fund, delivers a report on the performance of the fund in Q4 2020.

Read More
14.01.2021
BELLEVUE LOOKS BACK ON 2020

Bellevue Asset Management product specialists Markus Peter, Jean-Pierre Gerber and Loreno Ferrari look back on 2020 and explain what impact the corona crisis had on Bellevue's investment strategies and in which areas there is potential for 2021.

Read More
28.11.2020
WINNING THE DIGITAL HEALTH RACE

In the attached article Marcel Fritsch, portfolio manager of Bellevue's BB Adamant Digital Health Fund, proposes an analysis of the main growth drivers in the booming digital health sector.

Read More
27.08.2020
A new digital healthcare giant?
Stefan Blum, Portfolio Manager of the Adamant Global Medtech and Services e BB Adamant Digital Health funds discusses a recent acquisition which could represent an opportunity for the American merket and investors.
Read More
01.07.2020
A VIEW ON POST-COVID STRATEGIES

Raphael Pitoun, manager of the New City Global Equity Fund, shows how the recent market recovery was primarily driven by interest rates rather than fundamentals. In this presentation he presents his view on the stocks to consider for long term growth.

Read More
© 2022 - Fund Scouting & Advisory Ltd - All rights reserved
Fund Scouting Advisory LTD offers services to Professional clients only and it is authorized and regulated by Malta Financial Services Authority